Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled efficacy trial EP Sloan, M Koenigsberg, D Gens, M Cipolle, J Runge, MN Mallory, ... Jama 282 (19), 1857-1864, 1999 | 545 | 1999 |
Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions PC Hébert, D Fergusson, MA Blajchman, GA Wells, A Kmetic, D Coyle, ... Jama 289 (15), 1941-1949, 2003 | 483 | 2003 |
TRALI consensus panel M Goldman, KE Webert, DM Arnold, J Freedman, J Hannon, ... Proceedings of a consensus conference: towards an understanding of TRALI …, 2005 | 463 | 2005 |
Effects of the COVID-19 pandemic on supply and use of blood for transfusion SJ Stanworth, HV New, TO Apelseth, S Brunskill, R Cardigan, C Doree, ... The Lancet Haematology 7 (10), e756-e764, 2020 | 332 | 2020 |
Blood product-associated bacterial sepsis M Goldman, MA Blajchman Transfusion medicine reviews 5 (1), 73-83, 1991 | 305 | 1991 |
Proceedings of a consensus conference: towards an understanding of TRALI M Goldman, KE Webert, DM Arnold, J Freedman, J Hannon, ... Transfusion medicine reviews 19 (1), 2-31, 2005 | 239 | 2005 |
Improving the bacteriological safety of platelet transfusions MA Blajchman, M Goldman, F Baeza Transfusion medicine reviews 18 (1), 11-24, 2004 | 229 | 2004 |
Alloimmunization to platelet antigen HPA-1a (PIA1) is strongly associated with both HLA-DRB3∗ 0101 and HLA-DQB1∗ 0201 D L'Abbé, L Tremblay, M Filion, L Busque, M Goldman, F Décary, ... Human immunology 34 (2), 107-114, 1992 | 147 | 1992 |
Evaluation of donor skin disinfection methods M Goldman, G Roy, N Frechette, F Decary, L Massicotte, G Delage Transfusion 37 (3), 309-312, 1997 | 127 | 1997 |
Autologous donation error rates in Canada M Goldman, S Remy‐Prince, A Trepanier, F Decary Transfusion 37 (5), 523-527, 1997 | 120 | 1997 |
Selection criteria to protect the blood donor in North America and Europe: past (dogma), present (evidence), and future (hemovigilance) A Eder, M Goldman, S Rossmann, D Waxman, C Bianco Transfusion Medicine Reviews 23 (3), 205-220, 2009 | 118 | 2009 |
An animal model of allogeneic donor platelet refractoriness: the effect of the time of leukodepletion MA Blajchman, L Bardossy, RA Carmen, M Goldman, NM Heddle, ... | 118 | 1992 |
Bacterial contamination of platelet concentrates: incidence, significance, and prevention MA Blajchman, M Goldman Seminars in hematology 38, 20-26, 2001 | 117 | 2001 |
Canadian experience with detection of bacterial contamination in apheresis platelets S Ramírez‐Arcos, C Jenkins, J Dion, F Bernier, G Delage, M Goldman Transfusion 47 (3), 421-429, 2007 | 114 | 2007 |
Transfusion-related acute lung injury (TRALI) CP Engelfriet, HW Reesink, A Brand, M Palfi, MA Popovsky, ... Vox sanguinis 81 (4), 269-283, 2001 | 114 | 2001 |
Transfusion-transmitted malaria in Canada R Slinger, A Giulivi, M Bodie-Collins, F Hindieh, RS John, G Sher, ... Cmaj 164 (3), 377-379, 2001 | 111 | 2001 |
Proceedings of a consensus conference: prevention of post-transfusion CMV in the era of universal leukoreduction MA Blajchman, M Goldman, JJ Freedman, GD Sher Transfusion Medicine Reviews 15 (1), 1-20, 2001 | 109 | 2001 |
Transfusion‐related acute lung injury prevention measures and their impact at Canadian Blood Services Y Lin, CL Saw, B Hannach, M Goldman Transfusion 52 (3), 567-574, 2012 | 96 | 2012 |
Donor recruitment research D Devine, M Goldman, CP Engelfriet, HW Reesink, C Hetherington, S Hall, ... Vox sanguinis 93 (3), 250-259, 2007 | 94 | 2007 |
Bacterial contamination in platelets: incremental improvements drive down but do not eliminate risk C Jenkins, S Ramírez‐Arcos, M Goldman, DV Devine Transfusion 51 (12), 2555-2565, 2011 | 92 | 2011 |